Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-28FDA Approved: SOVALDI — Original Application (Gilead Sciences, Inc.)
The FDA approved Sovaldi (sofosbuvir) from Gilead as the original application for the treatment of chronic hepatitis C virus infection in ad…
-
FDA approval · 2019-08-28FDA Approved: HARVONI — Original Application (Gilead Sciences, Inc)
The FDA approved Harvoni (ledipasvir and sofosbuvir) from Gilead as an original application for the treatment of hepatitis C virus infection…
-
FDA approval · 2019-08-28FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc. The action updates the drug’s labeling and/o…
-
FDA approval · 2019-08-28FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
FDA approves a supplemental application for Ledipasvir and Sofosbuvir by Asegua Therapeutics LLC. The change pertains to the Ledipasvir and …
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating SH229 tablets in combination with daclatasvir dihydrochloride tablets for chronic hepatitis C is ongoi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Ledipasvir/Sofosbuvir fixed-dose combination in pediatric cancer patients with hepatitis…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Impact of Hepatitis C Therapy and Bone Health [Phase 4]
Phase 4 clinical trial update on the impact of hepatitis C therapy and bone health; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 [Phase 3]
Phase 3 trial of a fixed-dose combination (daclatasvir/asunaprevir/BMS-791325) for chronic hepatitis C genotype 1 has completed with posted …
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs [Phase 4]
Phase 4 trial evaluating immunologic effects of HARVONI therapy in Hepatitis C genotype 1 patients, including active and former IDUs; result…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Pilot HCV Direct Acting Antiviral Therapy and Metabolism [Phase 4]
Phase 4 pilot trial update on direct-acting antiviral therapy for hepatitis C and metabolism.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B [Phase 4]
Phase 4 proof-of-concept study evaluating OBV/PTV/r and DSV in adults with hepatitis C genotype 2k/1b, completed.
-
CLINICAL_TRIALS research · 2019-08-07Clinical Trial Update: An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C
An observational study assessing the safety of direct-acting antivirals in patients with chronic hepatitis C has completed with results post…
-
CLINICAL_TRIALS research · 2019-07-26Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary
Observational real-world evidence study assessing paritaprevir/ritonavir-ombitasvir with or without dasabuvir and/or ribavirin in chronic he…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Staged Phase I/II Hepatitis C Prophylactic Vaccine [Phase 1, Phase 2]
A staged Phase I/II clinical trial evaluated a prophylactic vaccine for Hepatitis C; status completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis [Phase 4]
Phase 4 trial update for PrOD in non-cirrhotic patients with hepatitis C genotype 1b on hemodialysis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir [Phase 2]
Phase 2 study evaluating AL-335, Odalasvir, and Simeprevir for Chronic Hepatitis C has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Transplantation Using Hepatitis C Positive Donors, A Safety Trial [Phase 3]
Phase 3 safety trial exploring transplantation using hepatitis C positive donors; results and status are unknown.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual [Phase 3]
Phase III trial update for Hepatitis C in China evaluating interferon intolerance and dual therapy approaches; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection [Phase 3]
A Phase 3 trial evaluating Glecaprevir/Pibrentasvir in adults with chronic HCV genotype 5 or 6 has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV [Phase 3]
Phase 3 trial of grazoprevir/elbasvir for acute hepatitis C in people with HIV has completed with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-07-05Clinical Trial Update: Helping Empower Liver and Kidney Patients [NA]
Clinical trial update from a completed study focused on liver and kidney conditions, including hepatitis C and chronic kidney disease, with …
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients [Phase 3]
A Phase 3 trial evaluating the combination of Seraprevir and Sofosbuvir in adults with chronic Hepatitis C genotype 1 infection.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C [Phase 3]
Phase 3 trial update for KW-136 with Sofosbuvir in Chinese adults with chronic hepatitis C completed.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia [Phase 3]
Phase 3 safety and efficacy study in subjects with chronic hepatitis C virus infection and underlying hemophilia has been completed with res…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France
Clinical trial update on the effectiveness of paritaprevir/ritonavir-ombitasvir ± dasabuvir ± ribavirin in France for chronic hepatitis C; s…